• Stronger and expanded international market access of OSSIS after acquisition by Zimmer Biomet
• Increased awareness of HyProtect™ coatings
• Increased volume of HyProtect™ coated implants
Nuremberg/Bremen – Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative technologies and individual solutions for health and hygiene, will introduce and market the innovative HyProtect™ coating technology into additional markets in the future via its long-term partner OSSIS Ltd. from New Zealand. The cooperation primarily relates to single patient compassionate care cases in human medicine with orthopedic revision implants.
Bio-Gate has already been successfully working together with OSSIS for several years, coating revision implants with the HyProtect™ technology. Bio-Gate coats titanium implants that are manufactured by Ossis using 3D printing and which are predominantly used in orthopedic revisions for patients who are particularly at risk of infection. Our cooperation partner recently accepted an acquisition offer from Zimmer Biomet – a global medical device technology manufacturer. The cooperation with Bio-Gate will continue unchanged and, due to the high quality of the HyProtect™ coating in the compassionate care sector, will now even be extended to further regions worldwide via the expanded global network.
Bio-Gate coated titanium implants have already been used in well over a hundred single-patient revision surgeries. Single-patient cases with antimicrobial implants are mainly performed in patients that are at risk of infection due to previous orthopedic revisions or in cancer patients. This is because in these patient groups, recent infections can lead to amputations or even have life-threatening consequences. Worldwide, patients in the EU, Switzerland, Great Britain, New Zealand, Australia and the USA have been treated with implants coated by Bio-Gate. In Germany, for example, implants have already been coated for high-risk patients at the Professional University Clinic Cooperative Murnau, University Clinic Regensburg, University Clinic Giessen.
The successful single patient revision cases have led to a strong interest among international clinics and surgeons. By now, Bio-Gate has accumulated an extensive amount of data from medical devices....READ MORE
March 2024- New study released by the Lancet shows that, in 2022, more than 1 billion people in the world are now living with obesity. Worldwide, obesity among adults has...
• Stronger and expanded international market access of OSSIS after acquisition by Zimmer Biomet • Increased awareness of HyProtect™ coatings • Increased volume of HyPro...
MULTIVAC at Compamed 2023 (13-16 November 2023) Wolfertschwenden, 28. September 2023 – MULTIVAC will be presenting itself (Hall 8a, Stand H01) at this year's C...
A virtual marketplace leading your business into the future
